Ten X Genomics Stock Surges, But Long-Term Challenges Persist

Markets & Money Today | 2 Min News | The Daily News Now! - En podcast af The Daily News Now! - Onsdage

Prøv Podimo gratis! i 30 dage

Prøv Podimo gratis! i 30 dage

Et univers fyldt med hundredvis af eksklusive podcasts & lydbøger, klik her for at prøve

 Annoncering
Podcast artwork

Kategorier:

Ekonomi

Ten X Genomics stock surges after Canaccord Genuity raises target price, following better-than-expected earnings. Despite recent gains, long-term investors still face challenges, as shares bought five years ago are now worth less than half their initial value.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site